LGI2 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

LGI2 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 10 amino acids near the center of human LGI2.

  Source: Synthetic

  (Accession #: Q8N0V4)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: LGI2
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76886.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for LGI2 Antibody Blocking Peptide

• FLJ10675
• glioma inactivated 2
• KIAA1916MGC126810
• leucine-rich repeat LGI family, member 2
• LGI1-like protein 2
• LGI2
• LGIL2
• MGC126808

Background

LGI2 gene's chromosomal location is 4p15.2 and encodes the Leucine-rich glioma-inactivated protein 2. The LGI2 gene is thought to play a part in epilepsy.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: LGI2